ASTHMA IN PREGNANCY - 02/09/11
Résumé |
Asthma is a chronic inflammatory disease of the airway system characterized by bronchoconstriction and bronchial hyperresponsiveness triggered by a host of stimuli. Asthma may complicate as many as 4% of pregnancies and is the most common respiratory disease in pregnancy.3
Retrospective studies demonstrate that untreated and uncontrolled asthma can produce serious morbidity and even mortality for the fetus and gravida. Contemporary management of the pregnant asthmatic is directed at controlling symptoms and treating the underlying cause of asthma, namely, inflammation. In the 1990s, the National Asthma Education Program (NAEP) was convened by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) for the purpose of developing guidelines and standards for the diagnosis and treatment of asthma.13
This article discusses the pathophysiology of asthma and the effects of asthma on pregnancy and vice versa, and reviews the NAEP guidelines for the treatment of asthma in pregnancy.
Le texte complet de cet article est disponible en PDF.Plan
| Address reprint requests to Paul J. Wendel, MD, Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Arkansas for Medical Sciences, 4301 West Markham, Mail Slot 518, Little Rock, AR 72205 |
Vol 28 - N° 3
P. 537-551 - septembre 2001 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
